Kaya Holdings (KAYS) Total Non-Current Liabilities (2014 - 2025)

Kaya Holdings (KAYS) recorded quarterly Total Non-Current Liabilities of $385742.0 in Q3 2025, down 95.92% quarter-over-quarter from $9.5 million in Q2 2025, and down 95.87% on a YoY basis from $9.3 million in Q3 2024.

Kaya Holdings (KAYS) Total Non-Current Liabilities (2014 - 2025) Analysis & Trends

Kaya Holdings' Total Non-Current Liabilities history runs 12 years deep, the most recent figure standing at $385742.0 for Q3 2025.

  • In Q3 2025, Total Non-Current Liabilities fell 95.87% year-over-year to $385742.0; the TTM figure through Sep 2025 stood at $385742.0 (down 95.87% YoY), while the FY2024 annual figure was $9.2 million, up 7.94% from the prior year.
  • Total Non-Current Liabilities was $385742.0 for Q3 2025 at Kaya Holdings, down from $9.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $9.5 million in Q2 2025 to a low of $385742.0 in Q3 2025.
  • Historically, Total Non-Current Liabilities has averaged $7.9 million across 5 years, with a median of $8.0 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities gained 15.1% in 2022, then sank 95.87% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $7.9 million in 2021, then advanced by 1.8% to $8.0 million in 2022, then advanced by 6.63% to $8.6 million in 2023, then gained by 7.94% to $9.2 million in 2024, then slumped by 95.83% to $385742.0 in 2025.
  • The last three Total Non-Current Liabilities figures came in at $385742.0 (Q3 2025), $9.5 million (Q2 2025), and $9.3 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 Kaya Holdings - - 5,370.00 385,742.00

Historic Data

Download Data
DateValue
Sep 30, 2025 385,742.00
Jun 30, 2025 9.45 Mn
Mar 31, 2025 9.33 Mn
Dec 31, 2024 9.24 Mn
Sep 30, 2024 9.34 Mn
Jun 30, 2024 8.99 Mn
Mar 31, 2024 8.79 Mn
Dec 31, 2023 8.56 Mn
Sep 30, 2023 8.45 Mn
Jun 30, 2023 8.37 Mn
Mar 31, 2023 8.03 Mn
Dec 31, 2022 8.03 Mn
Sep 30, 2022 7.96 Mn
Jun 30, 2022 7.98 Mn
Mar 31, 2022 7.91 Mn
Dec 31, 2021 7.89 Mn
Sep 30, 2021 6.98 Mn
Jun 30, 2021 6.94 Mn
Mar 31, 2021 6.99 Mn
Dec 31, 2020 6.92 Mn